The article Irwin Naturals Backs Out of Deal To Buy Braxia Scientific was originally published on Microdose. Back in January, we reported that Irwin Naturals...
Irwin said there was a 'lack of a clear business rationale' to complete the deal. The post Irwin Naturals Drops Bid to Buy Braxia Scientific appeared...
Irwin Natural's bid to snap up Braxia is also expected to close by the end of March. The post Braxia Scientific Sees Some Profit, Preps for...
The article Compass Pathways’ New Psilocybin For Depression Trial, Explained was originally published on Microdose. On February 17th, psychedelic medicine...
Serenity is expected to add $3 million in EBITDA to Irwin's financials. The post Irwin Naturals Acquires Kentucky Ketamine Clinic appeared first on Green...
The OTC asked the company to clarify if it had engaged in "pump-and-dump" schemes. The post OTC Flags Awakn Life Sciences for Stock Promotion appeared...
Potential for $60 million. The post Irwin Naturals Raises $40 Million For Clinic Expansion appeared first on Green Market Report.
Most psychedelics clinical trials have some degree of failure in that there are people in the trial who simply can’t tolerate psychedelics as a therapeutic...
Final price per share still to be determined. The post Irwin Naturals Signs LOI to Acquire Braxia Scientific appeared first on Green Market Report.
CeCors Inc (OTCMKTS: CEOS) is at heart a mushroom company with products on the shelf that is transforming into a disabled veteran benefits company. Many...